Market Tracker

01/20 5:16pm ET

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

123.88
Delayed Data
As of Jan 20
 -0.54 / -0.43%
Today’s Change
95.80
Today|||52-Week Range
160.00
+13.62%
Year-to-Date
Can Jazz Pharmaceuticals Be a Top Choice for Value Investors?
Jan 20 / Zacks.com - Paid Partner Content
Jazz Begins Phase III Study for Label Expansion of Defitelio
Jan 18 / Zacks.com - Paid Partner Content
Can Jazz Pharmaceuticals Be a Top Choice for Value Investors?
Jan 19 / Zacks.com - Paid Partner Content
Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers
Jan 18 / TheStreet.com - Paid Partner Content
5 Biotech Stocks You'll Want to Watch in the 1st Quarter
Jan 18 / MotleyFool.com - Paid Partner Content
Start the New Year off Right with 3 Best Biotech Stocks
Jan 08 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close124.42
Today’s open124.29
Day’s range122.83 - 125.28
Volume784,878
Average volume (3 months)655,106
Market cap$7.4B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+462.37%
Earnings growth (this year)+5.27%
Earnings growth (next 5 years)+14.10%
Revenue growth (last year)+12.95%
P/E ratio21.7
Price/Sales6.69
Price/Book4.75

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...+0.30+0.69%
TSROTESARO Inc-2.91-1.94%
SGENSeattle Genetics Inc-0.48-0.81%
UTHRUnited Therapeutics ...-0.84-0.55%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$2.65
Annual revenue (last year)$1.3B
Annual profit (last year)$329.5M
Net profit margin24.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Chief Operating Officer &
Executive Vice President
Russell J. Cox
Corporate headquarters
Dublin, Dublin

Forecasts